Emerging research suggest Retatru tide , a dual activator targeting both GLP-1 and another hormone, may represent a promising step forward for obesity loss . Early patient tests have shown considerable decreases in visceral fat , potentially surpassing other body composition treatments. Nevertheless , additional evaluation is needed to fully assess